"The
Report Chemotherapy Induced Neutropenia - Pipeline Review, H2 2016
provides information on pricing, market analysis, shares, forecast,
and company profiles for key industry participants. -
MarketResearchReports.biz"
Global Markets Directs,
Chemotherapy
Induced Neutropenia -
Pipeline Review, H2 2016, provides an overview of the Chemotherapy
Induced Neutropenia pipeline landscape.
The report provides
comprehensive information on the therapeutics under development for
Chemotherapy Induced Neutropenia, complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Chemotherapy Induced Neutropenia and
features dormant and discontinued projects.
Global Markets Directs report
features investigational drugs from across globe covering over 20
therapy areas and nearly 3,000 indications. The report is built using
data and information sourced from Global Markets Directs proprietary
databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press
releases from company/university sites and industry-specific third
party sources. Drug profiles featured in the report undergoes
periodic review following a stringent set of processes to ensure that
all the profiles are updated with the latest set of information.
Additionally, various dynamic tracking processes ensure that the most
recent developments are captured on a real time basis.
The report helps in identifying
and tracking emerging players in the market and their portfolios,
enhances decision making capabilities and helps to create effective
counter strategies to gain competitive advantage.
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/804925
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Chemotherapy Induced Neutropenia
-
The report reviews pipeline therapeutics for Chemotherapy Induced
Neutropenia by companies and universities/research institutes based
on information derived from company and industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Chemotherapy Induced
Neutropenia therapeutics and enlists all their major and minor
projects
-
The report assesses Chemotherapy Induced Neutropenia therapeutics
based on drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Chemotherapy Induced Neutropenia
Reasons
to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Chemotherapy Induced Neutropenia
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Chemotherapy Induced Neutropenia pipeline depth and focus of
Indication therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Table
of Contents
Table of Contents 2
List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report
Coverage 9
Chemotherapy Induced
Neutropenia Overview 10
Therapeutics Development 11
Pipeline Products for
Chemotherapy Induced Neutropenia - Overview 11
Pipeline Products for
Chemotherapy Induced Neutropenia - Comparative Analysis 12
Chemotherapy Induced
Neutropenia - Therapeutics under Development by Companies 13
Chemotherapy Induced
Neutropenia - Therapeutics under Investigation by
Universities/Institutes 16
Chemotherapy Induced
Neutropenia - Pipeline Products Glance 17
Late Stage Products 17
Clinical Stage Products 18
Early Stage Products 19
Unknown Stage Products 20
Chemotherapy Induced
Neutropenia - Products under Development by Companies 21
Chemotherapy Induced
Neutropenia - Products under Investigation by Universities/Institutes
23
Chemotherapy Induced
Neutropenia - Companies Involved in Therapeutics Development 24
Apotex Inc. 24
Biocon Limited 25
Biogenomics Limited 26
Bolder Biotechnology, Inc. 27
Cellerant Therapeutics, Inc. 28
Chong Kun Dang Pharmaceutical
Corp. 29
Cinfa Biotech S.L. 30
Dr. Reddy's Laboratories
Limited 31
Gene Techno Science Co., Ltd.
32
Generon (Shanghai) Corporation
Ltd. 33
Genexine, Inc. 34
Hanmi Pharmaceuticals, Co. Ltd.
35
Myelo Therapeutics GmbH 36
Octapharma AG 37
Pfenex Inc. 38
Pfizer Inc. 39
Reliance Life Sciences Pvt.
Ltd. 40
Richter Gedeon Nyrt. 41
Sandoz International GmbH 42
USV Limited 43
Chemotherapy Induced
Neutropenia - Therapeutics Assessment 44
Assessment by Monotherapy
Products 44
Assessment by Target 45
Assessment by Mechanism of
Action 47
Assessment by Route of
Administration 49
Assessment by Molecule Type 51
Drug Profiles 53
BBT-007 - Drug Profile 53
Product Description 53
Mechanism Of Action 53
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment